Andrew Kramar

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

X. Pivot, Gilles Romieu, Marc Debled et al. · The Lancet Oncology · 2013 · 338 citations

Medicine, Oncology, Breast Oncology +14

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

M. Spielmann, Henri Roché, T. Delozier et al. · Journal of Clinical Oncology · 2009 · 299 citations

Medicine, Oncology, Pharmacotherapy +17

Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database

Anja Lorch, Caroline Mollévi, Andrew Kramar et al. · Journal of Clinical Oncology · 2011 · 269 citations · Full text

Medicine, Oncology, Chemotherapy +15

CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 Patients

Mahmut Özsahin, N. E. A. Crompton, Sophie Gourgou et al. · Clinical Cancer Research · 2005 · 219 citations

Medicine, Oncology, Radiation Oncology +17

Gene Expression Signature in Advanced Colorectal Cancer Patients Select Drugs and Response for the Use of Leucovorin, Fluorouracil, and Irinotecan

Maguy Del Rio, Franck Molina, Caroline Mollévi et al. · Journal of Clinical Oncology · 2007 · 209 citations · Full text

Medicine, Molecular Medicine, Oncology +17